T. Mariani

Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology.

R. Motzer, J. Bacik, T. Mariani, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.

M. Bains, R. Motzer, J. Bacik, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.

J. Bacik, T. Mariani, M. Mazumdar, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Trial of Pyrazoloacridine in Patients with Cisplatin-Refractory Germ Cell Tumors

R. Motzer, T. Mariani, D. Bajorin, 2000, Investigational New Drugs.

Multiple congenital anomalies associated with apparently normal maternal intake of vitamin A: a phenocopy of the isotretinoin syndrome?

T. Mariani, D. Marinelli, M. Lungarotti, 1987, American journal of medical genetics.

Paclitaxel, I fosfamide, a nd C isplatin S econd-Line T herapy for P atients W ith R elapsed T esticular G erm C ell C ancer

M. Bains, R. Motzer, J. Bacik, 2000 .

Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients.

M. Bains, R. Motzer, T. Mariani, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.

L. Schwartz, R. Motzer, J. Bacik, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The functional assessment of cancer therapy–BRM (FACT–BRM): A new tool for the assessment of quality of life in patients treated with biologic response modifiers

R. Motzer, J. Bacik, T. Mariani, 2004, Quality of Life Research.

A phase II study of pyrazoloacridine in patients with advanced renal cell carcinoma

L. Schwartz, T. Mariani, M. Mazumdar, 2004, Investigational New Drugs.

Validation of the Italian version of the falls efficacy scale international (FES-I) and the short FES-I in community-dwelling older persons.

T. Mariani, F. Patacchini, F. Lattanzio, 2009, Archives of gerontology and geriatrics.